May 29th 2024, 4:09pm
Turning the focus to ibrutinib-based therapy, Yuliya Linhares, MD, gives an overview of the RESONATE study.
May 22nd 2024, 8:22pm
Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.
May 22nd 2024, 8:18pm
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
May 15th 2024, 1:49pm
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
May 15th 2024, 1:42pm
A general overview of efficacy and safety data for current treatment options for patients with chronic lymphocytic leukemia.
May 13th 2024, 7:20pm
“I think there is a very near future where we have available breast cancer vaccines for all of us, our children and for everybody,” said Kristen Dahlgren.
May 9th 2024, 7:30pm
An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.
May 8th 2024, 5:06pm
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
May 8th 2024, 4:38pm
Dr Linhares provides clinical insights on factors that guide treatment decisions for patients with chronic lymphocytic leukemia, such as comorbidities and disease biology.
May 7th 2024, 9:00pm
Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their hospital stay.
Aspiring to Make a Difference for Immigrants
Raising Awareness for Adolescents and Young Adults with Cancer
Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers
My 11-Year Metastatic Breast Cancer Story Defied the Standard Path